Bradley D. Robison, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 106 Farrar Dr, Suite 109, Cape Girardeau, MO 63701 Phone: 573-334-7055 Fax: 573-334-7961 |
Dr. Aleksey Aleksandrovich Androsov, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 211 Saint Francis Dr, Cape Girardeau, MO 63703 Phone: 573-331-5893 Fax: 573-331-5073 |
Dr. Reeta Rohatgi, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 402 S Silver Springs Rd, Cape Girardeau, MO 63703 Phone: 573-334-1100 Fax: 573-651-4345 |
Robert E Gardner, MD Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 3250 Gordonville Rd Ste 450, Cape Girardeau, MO 63703 Phone: 573-651-3188 Fax: 573-651-3048 |
Dr. Abdul B Chaudhari, M.D. Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 1723 Broadway, Suite 210, Cape Girardeau, MO 63701 Phone: 573-331-7840 Fax: 573-331-7849 |
Steven D Mellies, DO Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 3250 Gordonville Rd Ste 206, Cape Girardeau, MO 63703 Phone: 573-651-3188 Fax: 573-651-3048 |
Richard Daniel Ronca, Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 211 Saint Francis Dr, Cape Girardeau, MO 63703 Phone: 573-331-5893 Fax: 573-331-3974 |
Dr. Kishore A Khot, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 402 S Silver Springs Rd, Cape Girardeau, MO 63703 Phone: 573-334-1100 Fax: 573-651-4345 |
Dr. Robert E Mccool, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 402 S Silver Springs Rd, Cape Girardeau, MO 63703 Phone: 573-334-1100 Fax: 573-334-8819 |
John T Lake, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 60 Doctors Park Lowr Level, Cape Girardeau, MO 63703 Phone: 573-519-4949 Fax: 573-519-4665 |
Dr. Randall L Stahly, D.O. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 3004 Gordonville Rd, Cape Girardeau, MO 63703 Phone: 573-332-1972 Fax: 573-334-4667 |
Dr. Robert Earl Gardner Jr., MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 3250 Gordonville Rd Ste 450, Cape Girardeau, MO 63703 Phone: 573-651-3188 Fax: 573-651-3048 |
James J Laguardia, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 1723 Broadway St, Cape Girardeau, MO 63701 Phone: 573-331-7840 Fax: 573-331-7849 |
Dr. Elizabeth Jane Horton, M.D. Psychiatry & Neurology - Neurology with Special Qualifications in Child Neurology Medicare: Not Enrolled in Medicare Practice Location: 106 Farrar Dr, Suite 106, Cape Girardeau, MO 63701 Phone: 573-334-0067 Fax: 573-651-5455 |
David Y Lee, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 1359 N Mount Auburn Rd, Cape Girardeau, MO 63701 Phone: 573-651-3188 Fax: 573-651-3048 |
Dr. Mark Farrenburg, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 3004 Gordonville Rd, Cape Girardeau, MO 63703 Phone: 573-332-1972 Fax: 573-334-4667 |
Dr. Joseph Kadathalakunnel Sunny, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: Veterans Affairs Community Clinic, 2420 Veterans Memorial Dr, Cape Girardeau, MO 63701 Phone: 573-339-0909 Fax: 573-339-5940 |
News Archive
On the heels of the release of the highly anticipated Institute of Medicine (IOM) report, Public Health Effectiveness of the FDA 510(k) Clearance Process, The Food and Drug Law Institute (FDLI) is holding a "Dialogue" on the report August 4 in Washington, D.C.
NicOx S.A. (NYSE Euronext Paris: COX) today announced that an important scientific article has been published in the September issue of the American Journal of Cardiology. The publication describes the blood pressure results from the 301 phase 3 study for naproxcinod in detail. Naproxcinod is the first-in-class Cyclooxygenase-Inhibiting Nitric Oxide Donating (CINOD) anti-inflammatory agent for the relief of the signs and symptoms of osteoarthritis (OA).
A multifunctional drug delivery system consisting of a lipid-based nanoparticle, a standard anticancer drug, and a short nucleic acid designed to augment the activity of that drug has demonstrated the ability to treat drug-resistant tumor cells.
Employers prepared to pick up the cost of providing treatment for depression amongst their workers could reap benefits in terms of improved productivity and greater job retention.
› Verified 7 days ago